BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Laurus Labs Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
540222
ISIN Demat
INE947Q01028
Book Value (Rs)
97.2840104
NSE Symbol
LAURUSLABS
Divident Yield %
0.09
Market Cap
(Rs In Cr.)
71,647
P/E (TTM)
96.73
EPS (TTM)
13.72
Face Value
(Rs)
2
Back
Laurus Labs consolidated net profit rises 19.46% in the March 2026 quarter
30-Apr-26   Hrs IST

Net profit of Laurus Labs rose 19.46% to Rs 279.14 crore in the quarter ended March 2026 as against Rs 233.67 crore during the previous quarter ended March 2025. Sales rose 5.31% to Rs 1811.57 crore in the quarter ended March 2026 as against Rs 1720.30 crore during the previous quarter ended March 2025.

For the full year,net profit rose 148.04% to Rs 888.79 crore in the year ended March 2026 as against Rs 358.32 crore during the previous year ended March 2025. Sales rose 22.67% to Rs 6812.90 crore in the year ended March 2026 as against Rs 5553.96 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1811.571720.30 5 6812.905553.96 23
OPM %28.2724.45 -26.0919.00 -
PBDT483.47422.77 14 1661.93914.38 82
PBT361.37312.34 16 1181.88484.29 144
NP279.14233.67 19 888.79358.32 148

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)